Latest filing published 27 May 2021 for Veradigm Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.9%Entry US$12.45 · Close at T+365 US$14.80
- +38.5%Entry US$13.81 · Close at T+365 US$19.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David D. Stevens: trading record in brief
David D. Stevens, listed as board member, has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Medco Health Solutions Inc, Wright Medical Group N.V. and Veradigm Inc. The record holds 72 filings, for trades running from 11 May 2001 to 25 May 2021.
In open-market terms, that means 4 purchases worth €475k on one side and 8 sales worth €9.6M on the other. Netting one side against the other leaves €9.1M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 46 share grants and 4 option exercises.
In size, the median ticket on the buying side is €43k.
Most recently, on 27 May 2021, the filings show a share grant in Veradigm Inc. The clock since the last published purchase (12 November 2014) now reads 4,379 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David D. Stevens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,056 shares0Common StockSEC:0001209191-21-036283:0
- 99,666 shares@ US$30.7594.0% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-20-000129:0
- 30,582 shares0Common StockSEC:0001209191-20-031754:0
- 10,309 shares@ US$17.826.0% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-20-000017:0
- 3,916 shares0Ordinary Shares, par value EUR 0.03 per shareSEC:0001235802-19-000075:0
- 19,628 shares0Common StockSEC:0001209191-19-033242:0
- 10,309 shares@ US$15.014.5% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-19-000025:0
- 4,975 shares@ US$31.464.5% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-19-000025:1
- 3,804 shares0Ordinary Shares, par value EUR 0.03 per shareSEC:0001235802-18-000117:0
- 626 shares@ US$24.830.4% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-18-000117:1
- 15,949 shares0Common StockSEC:0001209191-18-032621:0
- 35,715 shares0Common StockSEC:0001209191-17-064438:0
- 3,586 shares0Ordinary Shares, par value EUR 0.03 per shareSEC:0001235802-17-000122:0
- 1,428 shares@ US$27.580.9% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-17-000111:0
- 16,765 shares0Common StockSEC:0001209191-17-034996:0
- 12,886 shares@ US$23.367.7% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-17-000029:0
- 11,807 shares@ US$28.018.5% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001235802-17-000029:1
- 1,177 shares@ US$23.710.7% of flowOrdinary Shares, par value EUR 0.03 per shareSEC:0001686266-16-000003:0
- 4,094 shares0Ordinary Shares, par value EUR 0.03 per shareSEC:0001235802-16-000276:0
- 15,129 shares0Common StockSEC:0001209191-16-123646:0
- 3,808 shares0Ordinary Shares, par value EUR 0.03 per shareSEC:0001235802-15-000149:0
- 66,966 sharesOrdinary Shares, par value EUR 0.03 per shareSEC:0000899243-15-006334:0
- 64,959 sharesCommon StockSEC:0000899243-15-006269:0
- 31,871 sharesCommon StockSEC:0001209191-15-049834:0
- 14,215 shares0Common StockSEC:0001209191-15-048365:0
25 of 63 declarations
